Baker Donelson

Search

Show All

Practices Industries

Business and Corporate

Coronavirus (COVID-19): Navigating the Path Ahead

Data Protection, Privacy and Cybersecurity

Emerging Companies

Financial Services

Global Business

Government Enforcement and Investigations

Government Relations and Public Policy

Hospitality, Franchising and Distribution

Intellectual Property

Labor & Employment

Mergers and Acquisitions

Product Liability and Mass Tort

Aviation and Aerospace

Disaster Recovery and Government Services

Drug, Device and Life Sciences

Financial Services

Governmental Entities

Higher Education

Hospitality, Franchising and Distribution

Telecommunications

Featured Case Study

Community Healthcare Trust Incorporated Community Healthcare Trust Incorporated More Case Studies

Search Experience

Professionals
Practices
Industries
Experience
News & Events
Other Pages

Quick Results

View More Results

Events

Challenging the Patentability of Genes

ABA Intellectual Property Litigation Roundtable Series

February 10, 2010
12:00 PM - 1:00 PM

Share

Location:

Baker, Donelson, Bearman, Caldwell & Berkowitz, PC
Birmingham, Alabama

Date/Time:

February 10, 2010
12:00 PM - 1:00 PM

Overview

Please join Patricia Clotfelter, shareholder in the Birmingham office, to discuss the ACLU's recent legal challenge to several breast gene patents, and to what extent (if any) human genes may be patentable.

Registration Contact

Brook Redmond: 205.244.3842

Events Contact

Heather Stripling

T: 205.250.8332

Email Professional

Speaker

Patricia Clotfelter

T: 205.250.8315

Email Professional

Related Practice

Intellectual Property

Online Payment Contact Us BakerConnect Extranet Disclaimer & Terms of Use Privacy Notice Security

©2020 Baker, Donelson, Bearman, Caldwell & Berkowitz, PC

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.

Cancel Accept